Medial branch block

Speaker 1...and this brings us to medial branch blocks, an interventional procedure often used to diagnose facet joint pain. We’re talking about pain and its complex relationship with aging and all-cause mortality.

Speaker 2Exactly. The idea here is that relieving pain, which these blocks can do for many, might slow down some aspects of biological aging. Unrelieved chronic pain itself is a known stressor.

Speaker 1Right. There's interesting evidence linking chronic pain to accelerated aging. For instance, a study in GeroScience 2025 (PMID 39847262) found painful diabetic neuropathy was associated with accelerated epigenetic aging and telomere shortening compared to painless neuropathy. This suggests pain itself can drive biological aging.

Speaker 2So, if medial branch blocks effectively manage that chronic pain, could they indirectly mitigate this accelerated aging? It's a compelling hypothesis.

Speaker 1It is, but the direct evidence showing medial branch blocks specifically impact biological aging or all-cause mortality long-term is still quite limited. These are typically diagnostic tools, and repeated use or the broader class of interventions needs careful study.

Speaker 2We don’t have robust, long-term trials connecting these specific procedures to changes in epigenetic clocks or overall longevity. While short-term pain relief is often clear and beneficial for appropriate candidates, translating that into a direct anti-aging effect or reduced all-cause mortality is unproven.

Speaker 1It's crucial to weigh the known benefits of pain relief – improved quality of life, mobility, reduced inflammation – against what we still don't know about the direct longevity impacts of specific interventions like medial branch blocks. It’s about managing pain to improve life, not necessarily extending it through this specific mechanism.